Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: VRTX

Vertex Pharmaceuticals Incorporated

Healthcare | Biotechnology

Market prices for VRTX are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$17.17

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-18 12:34 UTC.

What Vertex Pharmaceuticals Incorporated does

Vertex Pharmaceuticals is a global biotechnology company that develops medicines for serious diseases, particularly in specialty markets. The company has approved medicines for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain, and is advancing multiple mid- and late-stage clinical programs across additional serious diseases including kidney diseases, neuropathic pain, type 1 diabetes, and myotonic dystrophy type 1.

Summarized from Vertex Pharmaceuticals Incorporated’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$17.17
Return on equity21.18%

Revenue, margins & earnings

FY2021 Net income: $2.34BFY2021 Taxes & interest: $440MFY2021 Operating costs: $4.79B$7.57BFY2021FY2022 Net income: $3.32BFY2022 Taxes & interest: $985MFY2022 Operating costs: $4.62B$8.93BFY2022FY2023 Net income: $3.62BFY2023 Taxes & interest: $212MFY2023 Operating costs: $6.04B$9.87BFY2023FY2024: net loss $536M on revenue $11.0B$11.0BFY2024FY2025 Net income: $3.95BFY2025 Taxes & interest: $220MFY2025 Operating costs: $7.83B$12.0BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-10
  • 2026-09-10EVP, CP and NPPOAward8,682—
  • 2026-09-01SVP & Chief Accounting OfficerAward5,000—
  • 2026-08-31DirectorGift-6,000—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Vertex Pharmaceuticals Incorporated do?

Vertex Pharmaceuticals is a global biotechnology company that develops medicines for serious diseases, particularly in specialty markets.

When did VRTX last file with the SEC?

Vertex Pharmaceuticals Incorporated's most recent SEC filing on record is a 8-K filed 2026-07-07. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-18 12:34 UTC. This page is also available as JSON at /api/data?ticker=VRTX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for VRTX and 5,000+ tickers.

Create a free account — keep VRTX
For your agent
GET /api/data?ticker=VRTX

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt